Physician

Sarah Elizabeth Holy, MD

According to 2025 Medicare claims, Sarah Holy, MD (NPI: 1275514796) practices ophthalmology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF HOUSTON PLLC (NPI: 1619135647; TIN: 74-2109903) and primary practice location at 78258-4286.

Holy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,357 traditional Medicare patients, billed 48,098 HCPCS/CPT codes, and received $4,354,860 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 307 prescription claims across 133 beneficiaries totaling $17,362 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 6 records totaling $555. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,018,847 to $4,354,860. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $17,862 to $17,362. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.4M2015 Medicare payment: $2,018,847 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,297,550 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,335,965 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,109,914 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,387,961 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,895,331 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,066,953 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,197,570 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,555,276 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,354,860 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201597710,448$2,018,847
20161,12611,623$2,297,550
20171,12811,636$2,335,965
20181,09011,600$2,109,914
20191,11712,482$2,387,961
20201,06613,345$2,895,331
20211,16813,935$3,066,953
20221,27416,442$3,197,570
20231,27533,424$3,555,276
20241,35748,098$4,354,860

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$55K2015 Drug cost: $17,862 (USD; Tot_Drug_Cst)2016 Drug cost: $13,724 (USD; Tot_Drug_Cst)2017 Drug cost: $25,404 (USD; Tot_Drug_Cst)2018 Drug cost: $41,850 (USD; Tot_Drug_Cst)2019 Drug cost: $54,930 (USD; Tot_Drug_Cst)2020 Drug cost: $41,375 (USD; Tot_Drug_Cst)2021 Drug cost: $40,675 (USD; Tot_Drug_Cst)2022 Drug cost: $31,157 (USD; Tot_Drug_Cst)2023 Drug cost: $24,852 (USD; Tot_Drug_Cst)2024 Drug cost: $17,362 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201579202$17,862
201690202$13,724
2017105326$25,404
2018102323$41,850
2019101291$54,930
202078284$41,375
202187247$40,675
202294253$31,157
2023110297$24,852
2024133307$17,362

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2221,952$652
67028Injection of drug into eye4752,001$98
92014Established patient complete exam of visual system1,0161,332$90
92134Imaging of retina1,2383,099$30
92250Photography of the retina225242$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate833,065$2,817
Brimonidine TartrateBrimonidine Tartrate161,103$1,278
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat342,693$707
LatanoprostLatanoprost281,625$311
TobramycinTobramycin641,554$301

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$555Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sarah Elizabeth Holy, MD?

Tedicare shows public-source Medicare data for Sarah Elizabeth Holy, MD (NPI 1275514796), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Elizabeth Holy, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sarah Elizabeth Holy, MD?

Sarah Elizabeth Holy, MD is linked to RETINA CONSULTANTS OF HOUSTON PLLC (billing NPI 1619135647) in the available physician profile data.

Does Sarah Elizabeth Holy, MD have Open Payments data?

Sarah Elizabeth Holy, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.